 | Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Expected to Post Quarterly Sales of $165.23 Million
www.americanbankingnews.com - June 13 at 5:30 AM |
 | Hedge Funds Are Dumping Neurocrine Biosciences, Inc. (NBIX)
finance.yahoo.com - June 11 at 6:51 PM |
| Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2019 World Congress on Parkinson's Disease and Related Disorders
finance.yahoo.com - June 11 at 6:51 PM |
| Brokerages Expect Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Will Post Earnings of $0.27 Per Share
www.americanbankingnews.com - June 11 at 2:14 AM |
| Neurocrine Biosciences, Inc. (NBIX) Insider Sells $293,726.85 in Stock
www.americanbankingnews.com - June 5 at 8:39 PM |
| Neurocrine Biosciences to Present at Goldman Sachs 40th Annual Global Healthcare Conference
finance.yahoo.com - June 4 at 6:29 PM |
| Neurocrine Biosciences (NBIX) Research Coverage Started at Guggenheim
www.americanbankingnews.com - June 4 at 6:27 PM |
| Neurocrine Biosciences, Inc. (NBIX) Insider Sells $1,640,630.94 in Stock
www.americanbankingnews.com - June 3 at 8:19 PM |
 | First Week of July 19th Options Trading For Neurocrine Biosciences (NBIX)
www.nasdaq.com - June 3 at 6:32 PM |
| Is Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Trading At A 30% Discount?
finance.yahoo.com - May 31 at 6:34 PM |
| Traders Purchase Large Volume of Call Options on Neurocrine Biosciences (NBIX)
www.americanbankingnews.com - May 31 at 8:09 AM |
| Neurocrine Biosciences to Present at Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 30 at 6:21 PM |
| Neurocrine Biosciences, Inc. (NBIX) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 30 at 3:23 AM |
| Haig P. Bozigian Sells 17,486 Shares of Neurocrine Biosciences, Inc. (NBIX) Stock
www.americanbankingnews.com - May 29 at 8:16 PM |
| Neurocrine Biosciences, Inc. (NBIX) Insider Haig P. Bozigian Sells 1,300 Shares
www.americanbankingnews.com - May 23 at 8:32 PM |
 | AbbVie Launches ORILISSA(TM) (elagolix) 200 mg BID Dose for the Treatment of Moderate to Severe Pain Associated with Endometriosis
www.marketwatch.com - May 21 at 11:20 AM |
 | AbbVie launches higher dose Orilissa
seekingalpha.com - May 21 at 11:20 AM |
| AbbVie Launches ORILISSA™ (elagolix) 200 mg BID Dose for the Treatment of Moderate to Severe Pain Associated with Endometriosis
finance.yahoo.com - May 21 at 11:20 AM |
| Neurocrine Biosciences Presents New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia, Demonstrating the Effect of Involuntary Movements on Patient Quality of Life
finance.yahoo.com - May 20 at 9:28 AM |
| Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2019 American Psychiatric Association Annual Meeting
finance.yahoo.com - May 16 at 7:26 PM |
| Neurocrine Biosciences to Present at Bank of America Merrill Lynch Health Care Conference 2019
finance.yahoo.com - May 7 at 6:40 PM |
| Neurocrine Biosciences Honors Mental Health Month and Raises Awareness of Tardive Dyskinesia and its Impact on Patients
www.marketwatch.com - May 6 at 8:48 AM |
 | Neurocrine Biosciences Presents Phase III Data Analysis Demonstrating that Opicapone Added to Levodopa Resulted in a Significant and Sustained Increase in ON Time without Troublesome Dyskinesia in Parkinson's Disease Patients with Motor Fluctuations
www.prnewswire.com - May 5 at 9:34 AM |
| Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson's Disease at the American Academy of Neurology Annual Meeting
www.prnewswire.com - May 5 at 9:34 AM |
| Neurocrine Drifting, But The Total Package Is Still Appealing
seekingalpha.com - April 30 at 6:33 PM |
| Neurocrine Biosciences to Present Data Analyses on INGREZZA® (valbenazine) and Opicapone at the 2019 American Academy of Neurology Annual Meeting
finance.yahoo.com - April 30 at 6:33 PM |
| Edited Transcript of NBIX earnings conference call or presentation 29-Apr-19 8:30pm GMT
finance.yahoo.com - April 30 at 8:41 AM |
 | Neurocrine Biosciences Inc (NBIX) Q1 2019 Earnings Call Transcript
www.fool.com - April 30 at 12:10 AM |
| First Week of NBIX June 21st Options Trading
www.nasdaq.com - April 29 at 6:25 PM |
| Neurocrine Biosciences Reports First Quarter 2019 Financial Results
www.marketwatch.com - April 29 at 6:25 PM |
| Neurocrine Biosciences Q1 2019 Earnings Preview
seekingalpha.com - April 29 at 8:38 AM |
| Did Hedge Funds Drop The Ball On Neurocrine Biosciences, Inc. (NBIX) ?
finance.yahoo.com - April 21 at 8:50 AM |
| Is Neurocrine Biosciences, Inc. (NASDAQ:NBIX) A Financially Sound Company?
finance.yahoo.com - April 16 at 7:21 PM |
| United States : Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2019 Financial Results
www.marketwatch.com - April 10 at 7:58 PM |
| Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2019 Financial Results
finance.yahoo.com - April 8 at 7:28 PM |
| Analysts Raise Neurocrine Biosciences’ Target Price in March
finance.yahoo.com - March 29 at 7:11 PM |
| Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinson’s Disease in the Annals of Neurology
finance.yahoo.com - March 28 at 7:03 PM |
| Noteworthy Thursday Option Activity: NBIX, CRUS, C
www.nasdaq.com - March 21 at 7:18 PM |
| Neurocrine Biosciences: Rapid Pipeline Expansion Underway
seekingalpha.com - March 19 at 7:14 PM |
| Neurocrine Biosciences May Have Something Interesting With NBI-74788
seekingalpha.com - March 13 at 6:48 PM |
| Neurocrine Bio's NBI-74788 shows positive action in mid-stage adrenal hyperplasia study
seekingalpha.com - March 12 at 9:12 AM |
| Neurocrine Biosciences Reports Positive Interim Results from Phase II Study of NBI-74788 in Adults with Classic Congenital Adrenal Hyperplasia
finance.yahoo.com - March 12 at 9:12 AM |
| Why These 2 Biotech Stocks Might Be Next On The Takeover List
finance.yahoo.com - March 1 at 6:39 PM |
| Why Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Is An Attractive Investment To Consider
finance.yahoo.com - February 28 at 6:42 PM |
| Neurocrine Dives Into Gene Therapy
seekingalpha.com - February 27 at 6:57 PM |
 | CTLT vs. NBIX: Which Stock Should Value Investors Buy Now?
www.zacks.com - February 12 at 8:46 AM |
| Edited Transcript of NBIX earnings conference call or presentation 5-Feb-19 9:30pm GMT
finance.yahoo.com - February 7 at 8:45 AM |
| Neurocrine Biosciences Inc (NBIX) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 5 at 9:49 PM |
| Neurocrine Bio Q4 Ingrezza sales up 102%; earnings up 162%
seekingalpha.com - February 5 at 6:07 PM |
| Neurocrine Biosciences (NBIX) Beats Q4 Earnings Estimates
www.zacks.com - February 5 at 6:07 PM |
